Human Genome Epidemiology Literature Finder
|
Records 1 - 27 (of 27 Records) |
| Query Trace: Trisomy and IGHV[original query] |
|---|
| NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2012 Mar 97 (3): 437-41. Del Giudice Ilaria, Rossi Davide, Chiaretti Sabina, Marinelli Marilisa, Tavolaro Simona, Gabrielli Sara, Laurenti Luca, Marasca Roberto, Rasi Silvia, Fangazio Marco, Guarini Anna, Gaidano Gianluca, Foà Rob |
| The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 2013 Jan 121 (3): 468-75. Oscier David G, Rose-Zerilli Matthew J J, Winkelmann Nils, Gonzalez de Castro David, Gomez Belen, Forster Jade, Parker Helen, Parker Anton, Gardiner Anne, Collins Andrew, Else Monica, Cross Nicholas C P, Catovsky Daniel, Strefford Jonathan |
| Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance. Genes, chromosomes & cancer 2013 Oct 52 (10): 920-7. López Cristina, Delgado Julio, Costa Dolors, Villamor Neus, Navarro Alba, Cazorla Maite, Gómez Cándida, Arias Amparo, Muñoz Concha, Cabezas Sandra, Baumann Tycho, Rozman María, Aymerich Marta, Colomer Dolors, Pereira Arturo, Cobo Francesc, López-Guillermo Armando, Campo Elías, Carrió A |
| SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia 2014 Jan 28 (1): 108-17. Jeromin S, Weissmann S, Haferlach C, Dicker F, Bayer K, Grossmann V, Alpermann T, Roller A, Kohlmann A, Haferlach T, Kern W, Schnittger |
| NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2012 Dec . Villamor N, Conde L, Martínez-Trillos A, Cazorla M, Navarro A, Beà S, López C, Colomer D, Pinyol M, Aymerich M, Rozman M, Abrisqueta P, Baumann T, Delgado J, Giné E, González-Díaz M, Hernández JM, Colado E, Payer AR, Rayon C, Navarro B, José Terol M, Bosch F, Quesada V, Puente XS, López-Otín C, Jares P, Pereira A, Campo E, López-Guillermo A |
| Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia 2015 Feb 29 (2): 329-36. Baliakas P, Hadzidimitriou A, Sutton L-A, Rossi D, Minga E, Villamor N, Larrayoz M, Kminkova J, Agathangelidis A, Davis Z, Tausch E, Stalika E, Kantorova B, Mansouri L, Scarfò L, Cortese D, Navrkalova V, Rose-Zerilli M J J, Smedby K E, Juliusson G, Anagnostopoulos A, Makris A M, Navarro A, Delgado J, Oscier D, Belessi C, Stilgenbauer S, Ghia P, Pospisilova S, Gaidano G, Campo E, Strefford J C, Stamatopoulos K, Rosenquist R, |
| 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma. Genes, chromosomes & cancer 2014 Aug 53 (8): 657-66. Cosson Adrien, Chapiro Elise, Belhouachi Nabila, Cung Hong-Anh, Keren Boris, Damm Frederik, Algrin Caroline, Lefebvre Christine, Fert-Ferrer Sandra, Luquet Isabelle, Gachard Nathalie, Mugneret Francine, Terre Christine, Collonge-Rame Marie-Agnes, Michaux Lucienne, Rafdord-Weiss Isabelle, Talmant Pascaline, Veronese Lauren, Nadal Nathalie, Struski Stephanie, Barin Carole, Helias Catherine, Lafage Marina, Lippert Eric, Auger Nathalie, Eclache Virginie, Roos-Weil Damien, Leblond Veronique, Settegrana Catherine, Maloum Karim, Davi Frederic, Merle-Beral Helene, Lesty Claude, Nguyen-Khac Florence, |
| NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. Leukemia & lymphoma 2014 Dec 55 (12): 2785-92. Chiaretti Sabina, Marinelli Marilisa, Del Giudice Ilaria, Bonina Silvia, Piciocchi Alfonso, Messina Monica, Vignetti Marco, Rossi Davide, Di Maio Valeria, Mauro Francesca Romana, Guarini Anna, Gaidano Gianluca, Foà Rob |
| Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia. PloS one 2015 10 (3): e0118801. Maura Francesco, Mosca Laura, Fabris Sonia, Cutrona Giovanna, Matis Serena, Lionetti Marta, Agnelli Luca, Barbieri Marzia, D'Anca Marianna, Manzoni Martina, Colombo Monica, Massucco Carlotta, Reverberi Daniele, Gentile Massimo, Recchia Anna Grazia, Bossio Sabrina, Ilariucci Fiorella, Musolino Caterina, Di Raimondo Francesco, Cortelezzi Agostino, Morabito Fortunato, Ferrarini Manlio, Neri Antoni |
| Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia. Hematological oncology 2016 Sep . Le Bris Yannick, Struski Stéphanie, Guièze Romain, Rouvellat Caroline, Prade Naïs, Troussard Xavier, Tournilhac Olivier, Béné Marie C, Delabesse Eric, Ysebaert Lo |
| The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial. British journal of haematology 2016 May . Oscier David, Else Monica, Matutes Estella, Morilla Ricardo, Strefford Jonathan C, Catovsky Dani |
| Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia. PloS one 2017 12 (6): e0179883. Dos Santos Patricia Carolina, Panero Julieta, Stanganelli Carmen, Palau Nagore Virginia, Stella Flavia, Bezares Raimundo, Slavutsky Ir |
| Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia. Leukemia & lymphoma 2017 Jun 1-10. Sandoval-Sus Jose D, Chavez Julio C, Dalia Samir, Naqvi Syeda Mahrukh Hussnain, Talati Chetasi, Nodzon Lisa, Kharfan-Dabaja Mohamed A, Pinilla-Ibarz Javi |
| The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. Hematology. American Society of Hematology. Education Program 2017 12 2017 (1): 329-337. Gaidano Gianluca, Rossi Davi |
| Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group. Genes, chromosomes & cancer 2018 Sep . Roos-Weil Damien, Nguyen-Khac Florence, Chevret Sylvie, Touzeau Cyrille, Roux Clémence, Lejeune Julie, Cosson Adrien, Mathis Stéphanie, Feugier Pierre, Leprêtre Stéphane, Béné Marie-Christine, Baron Marine, Raynaud Sophie, Struski Stéphanie, Eclache Virginie, Sutton Laurent, Lesty Claude, Merle-Béral Hélène, Cymbalista Florence, Ysebaert Loïc, Davi Frédéric, Leblond Véronique, |
| [Clinical analysis of 70 chronic lymphocytic leukemia patients with trisomy 12 detected by FISH]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2018 5 39 (5): 387-391. Lyu R, Li Z J, Li H, Yi S H, Liu W, Wang T Y, Xiong W J, Qiu L |
| NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases. Cancer medicine 2018 Mar . Zou Yixin, Fan Lei, Xia Yi, Miao Yi, Wu Wei, Cao Lei, Wu Jiazhu, Zhu Huayuan, Qiao Chun, Wang Li, Xu Wei, Li Jianyo |
| Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood 2019 9 134 (21): 1821-1831. Chapiro Elise, Pramil Elodie, Diop M'boyba, Roos-Weil Damien, Dillard Clémentine, Gabillaud Clémentine, Maloum Karim, Settegrana Catherine, Baseggio Lucile, Lesesve Jean-François, Yon Mélanie, Jondreville Ludovic, Lesty Claude, Davi Frédéric, Le Garff-Tavernier Magali, Droin Nathalie, Dessen Philippe, Algrin Caroline, Leblond Véronique, Gabarre Jean, Bouzy Simon, Eclache Virginie, Gaillard Baptiste, Callet-Bauchu Evelyne, Muller Marc, Lefebvre Christine, Nadal Nathalie, Ittel Antoine, Struski Stéphanie, Collonge-Rame Marie-Agnès, Quilichini Benoit, Fert-Ferrer Sandra, Auger Nathalie, Radford-Weiss Isabelle, Wagner Lena, Scheinost Sebastian, Zenz Thorsten, Susin Santos A, Bernard Olivier A, Nguyen-Khac Florence, , |
| Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia. British journal of haematology 2019 6 187 (1): 82-92. Huang Ying-Jung, Kuo Ming-Chung, Chang Hung, Wang Po-Nan, Wu Jin-Hou, Huang Yen-Min, Ma Ming-Chun, Tang Tzung-Chih, Kuo Ching-Yuan, Shih Lee-Yu |
| Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. Leukemia research 2019 Apr 81 75-81. Spunarova Michaela, Tom Nikola, Pavlova Sarka, Mraz Marek, Brychtova Yvona, Doubek Michael, Panovska Anna, Skuhrova Francova Hana, Brzobohata Anna, Pospisilova Sarka, Mayer Jiri, Trbusek Mart |
| Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia. Haematologica 2020 May . Heerema Nyla A, Muthusamy Natarajan, Zhao Qiuhong, Ruppert Amy S, Breidenbach Heather, Andritsos Leslie A, Grever Michael R, Maddocks Kami J, Woyach Jennifer, Awan Farrukh, Long Meixiao, Gordon Amber, Coombes Caitlin, Byrd John |
| Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG). Haematologica 2020 11 105 (11): 2598-2607. Jaramillo Sonia, Agathangelidis Andreas, Schneider Christof, Bahlo Jasmin, Robrecht Sandra, Tausch Eugen, Bloehdorn Johannes, Hoechstetter Manuela, Fischer Kirsten, Eichhorst Barbara, Goede Valentin, Hallek Michael, Döhner Hartmut, Rosenquist Richard, Ghia Paolo, Stamatopoulos Kostas, Stilgenbauer Steph |
| Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leukemia research 2022 4 116 106827. Jelloul Fatima Zahra, Yang Richard, Garces Sofia, Kanagal-Shamanna Rashmi, Ok Chi Y, Loghavi Sanam, Routbort Mark J, Zuo Zhuang, Yin C Cameron, Floyd Kristen, Bassett Roland L, Wierda William, Jain Nitin, Thompson Philip, Luthra Rajyalakshmi, Medeiros L Jeffrey, Patel Keyur |
| High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL. HemaSphere 2023 9 7 (10): e951. Paul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, Wouter Doff, Julie M N Dubois, Melissa Rijken, Jorn L J C Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten J Gussinklo, Peter J M Valk, Laura M Faber, Peter E Westerweel, Arnon P Kater, Mark-David Levin, Anton W Langer |
| Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
| Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles. Frontiers in oncology 2023 3 13 1120867. Deng Xinyue, Zhang Meilan, Wang Jiachen, Zhou Xiaoxi, Xiao M |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
- Page last reviewed:Feb 1, 2024
- Content source: